drugset / Trial / NCT00573768

Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Patients With Acute Ankle Sprain

NCT00573768

Phase 2 Completed 271 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the efficacy of diclofenac diethylamine 2.32% gel in the treatment of acute ankle sprain.

Timeline

Start
2007-11
Primary completion
2007-12
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac diethylamine Unknown 2.32 % Topical

Indications

No indication recorded.